Collomp K, Arlettaz A, Portier H, Lecoq A-M, Le Panse B, Rieth N, De Ceaurriz J
Laboratoire Activité Physique, Santé et Performance, UFR STAPS, Université d'Orléans, Orleans, France.
Br J Sports Med. 2008 Dec;42(12):983-8. doi: 10.1136/bjsm.2007.043083. Epub 2007 Nov 29.
To investigate the effects of short-term prednisolone ingestion combined with intense training on exercise performance, hormonal (adrenocorticotrophic hormone (ACTH), prolactin, luteinising hormone (LH), growth hormone (GH), thyroid-stimulating hormone (TSH), dehydroepiandrosterone (DHEA), testosterone, insulin) and metabolic parameters (blood glucose, lactate, bicarbonate, pH).
Eight male recreational athletes completed four cycling trials at 70-75% peak O(2) consumption until exhaustion just before (1) and after (2) either oral placebo or prednisolone (60 mg/day for 1 week) treatment coupled with standardised physical training (2 hours/day), according to a double-blind and randomised protocol. Blood samples were collected at rest, during exercise and passive recovery for the hormonal and metabolic determinations.
Time of cycling was not significantly changed after placebo but significantly increased (p<0.05) after prednisolone administration (50.4 (6.2) min for placebo 1, 64.0 (9.1) min for placebo 2, 56.1 (9.1) min for prednisolone 1 and 107.0 (20.7) min for prednisolone 2). There was no significant difference in any measured parameters after the week of training with placebo but a decrease in ACTH, DHEA, PRL, GH, TSH and testosterone was seen with prednisolone treatment during the experiment (p<0.05). No significant change in basal, exercise or recovery LH, insulin, lactate, pH or bicarbonate was found between the two treatment, but blood glucose was significantly higher under prednisolone (p<0.05) at all time points.
Short-term glucocorticoid administration induced a marked improvement in endurance performance. Further studies are needed to determine whether these results obtained in recreational male athletes maintaining a rigorous training schedule are gender-dependent and applicable to elite athletes.
研究短期服用泼尼松龙联合高强度训练对运动表现、激素(促肾上腺皮质激素(ACTH)、催乳素、黄体生成素(LH)、生长激素(GH)、促甲状腺激素(TSH)、脱氢表雄酮(DHEA)、睾酮、胰岛素)和代谢参数(血糖、乳酸、碳酸氢盐、pH值)的影响。
八名男性业余运动员按照双盲随机方案,在口服安慰剂或泼尼松龙(60毫克/天,共1周)治疗并结合标准化体育训练(每天2小时)之前(1)和之后(2),以最大耗氧量的70 - 75%进行四次自行车耐力测试,直至力竭。在静息、运动期间和被动恢复过程中采集血样,用于激素和代谢测定。
服用安慰剂后自行车骑行时间无显著变化,但服用泼尼松龙后显著增加(p<0.05)(安慰剂1组为50.4(6.2)分钟,安慰剂2组为64.0(9.1)分钟,泼尼松龙1组为56.1(9.1)分钟,泼尼松龙2组为107.0(20.7)分钟)。服用安慰剂训练一周后,所有测量参数均无显著差异,但在实验期间,泼尼松龙治疗使ACTH、DHEA、PRL、GH、TSH和睾酮水平降低(p<0.05)。两种治疗之间,基础、运动或恢复过程中的LH、胰岛素、乳酸、pH值或碳酸氢盐均无显著变化,但在所有时间点,泼尼松龙治疗组的血糖均显著升高(p<0.05)。
短期给予糖皮质激素可显著提高耐力表现。需要进一步研究以确定在保持严格训练计划的男性业余运动员中获得的这些结果是否具有性别依赖性,以及是否适用于精英运动员。